Hypoglycemia Abrogates the Vascular Endothelial Protective Effect of Exenatide in Type 2 Diabetes Mellitus

Full copyright for enhanced digital features is owned by the authors. Article full text The full text of this article can be found here. Provide enhanced digital features for this article If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact [email protected]. The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content. Other enhanced features include, but are not limited to: • Slide decks • Videos and animations • Audio abstracts • Audio slides</p

Molecular Transformations of Unsaturated Thiacrown Ethers

Unsaturated thiacrown ethers with 15, 18, and 21 members were oxidized to sulfoxides by the reaction with m-CPBA. The reaction with t-BuOCl at −20 °C also afforded sulfoxides, whereas the reaction at room temperature yielded cis−trans isomerized compounds. The cis−trans isomerized compound was also obtained by the photochemical reaction or by the reaction with NCS and NCP. Meanwhile, the reaction with NBS and NBP provided an acetal via 1,2-bridged bromonium intermediate

Molecular Transformations of Unsaturated Thiacrown Ethers

Unsaturated thiacrown ethers with 15, 18, and 21 members were oxidized to sulfoxides by the reaction with m-CPBA. The reaction with t-BuOCl at −20 °C also afforded sulfoxides, whereas the reaction at room temperature yielded cis−trans isomerized compounds. The cis−trans isomerized compound was also obtained by the photochemical reaction or by the reaction with NCS and NCP. Meanwhile, the reaction with NBS and NBP provided an acetal via 1,2-bridged bromonium intermediate

Molecular Transformations of Unsaturated Thiacrown Ethers

Unsaturated thiacrown ethers with 15, 18, and 21 members were oxidized to sulfoxides by the reaction with m-CPBA. The reaction with t-BuOCl at −20 °C also afforded sulfoxides, whereas the reaction at room temperature yielded cis−trans isomerized compounds. The cis−trans isomerized compound was also obtained by the photochemical reaction or by the reaction with NCS and NCP. Meanwhile, the reaction with NBS and NBP provided an acetal via 1,2-bridged bromonium intermediate

Molecular Transformations of Unsaturated Thiacrown Ethers

Unsaturated thiacrown ethers with 15, 18, and 21 members were oxidized to sulfoxides by the reaction with m-CPBA. The reaction with t-BuOCl at −20 °C also afforded sulfoxides, whereas the reaction at room temperature yielded cis−trans isomerized compounds. The cis−trans isomerized compound was also obtained by the photochemical reaction or by the reaction with NCS and NCP. Meanwhile, the reaction with NBS and NBP provided an acetal via 1,2-bridged bromonium intermediate

Molecular Transformations of Unsaturated Thiacrown Ethers

Unsaturated thiacrown ethers with 15, 18, and 21 members were oxidized to sulfoxides by the reaction with m-CPBA. The reaction with t-BuOCl at −20 °C also afforded sulfoxides, whereas the reaction at room temperature yielded cis−trans isomerized compounds. The cis−trans isomerized compound was also obtained by the photochemical reaction or by the reaction with NCS and NCP. Meanwhile, the reaction with NBS and NBP provided an acetal via 1,2-bridged bromonium intermediate

Supplementary data for "Pathological role of Th17 cells in Graves' disease."

Supplementary data for "Pathological role of Th17 cells in Graves' disease.

IL-17 suppressed the expression of chondrogenic marker genes.

<p>Human MSCs were cultured as aggregates in TGF-β3-containing medium with the indicated concentrations of IL-17. After 14 days, type II collagen (<i>COL2A1</i>), aggrecan (<i>ACAN</i>), type X collagen (<i>COL10A1</i>), and alkaline phosphatase (<i>ALP</i>) mRNA levels were determined by real-time PCR and expressed relative to β-actin expression level. Values are mean±SD of 3 aggregates from 1 of 3 independent experiments with similar findings.</p

IL-17 treatment reduces PKA activity during chondrogenesis.

<p>A, Human MSCs were cultured as aggregates with TGF-β3 in the presence of IL-17 (100 ng/mL) or H89 (10 µM). After 7 days, 3 aggregates were pooled and lysed in each group, and PKA activity within the soluble protein fraction was determined using PepTag non-radioactive PKA assay (top). Recombinant PKA catalytic subunit (2 µg/mL) was used as a positive control and water was used as a negative control. Densitometric analyses of the band intensities were performed and results were expressed as the test band intensity relative to that of the “no TGF-β3” sample (bottom). B, The DNA content of three aggregates in each group was measured after 7-day culture. Values shown in A and B are mean±SD of three independent experiments. **<i>P<</i>0.01 compared to no cytokine (+TGF-β3), by Dunnett’s multiple comparison test.</p

PKA activation is required for chondrogenic differentiation of human MSCs.

<p>A, Paraffin sections from aggregates cultured in the presence of 10 µM H89 for 21 days were stained with Safranin O and anti-type II collagen antibody. Original magnification×10. Scale bars represent 500 µm. B, <i>COL2A1, ACAN, COL10A1</i>, and <i>ALP</i> mRNA levels in aggregates treated with the indicated concentrations of H89 for 21 days were determined by real-time PCR. Values are mean±SD of three aggregates from 1 of 2 independent experiments with similar findings. See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0079463#pone-0079463-g001" target="_blank">Figures 1</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0079463#pone-0079463-g002" target="_blank">2</a> for the definition of other symbols.</p